3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Sarcoma
16
Central Nervous System Neoplasms
10
Gliosarcoma
9
Glioblastoma
9
Osteosarcoma
8
Astrocytoma
6
Sarcoma, Ewing
5
Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma
3
Lung Neoplasms
3
Breast Neoplasms
3
Brain Neoplasms
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Extranodal NK-T-Cell
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia
2
Glioma
2
Esophageal Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Colorectal Neoplasms
2
Interventions
Doxorubicin
17
Cyclophosphamide
16
Ifosfamide
11
fludarabine
9
Radiotherapy
8
tazemetostat
5
pembrolizumab
4
pazopanib
4
Gemcitabine
4
pegfilgrastim
3
cixutumumab
3
Trabectedin
3
Radiation
3
Imatinib Mesylate
3
Filgrastim
3
Docetaxel
3
Dacarbazine
3
sargramostim
2
liposomal doxorubicin
2
fludarabine phosphate
2
brostallicin
2
aldesleukin
2
X-Rays
2
Sunitinib
2
Specimen Handling
2
Sorafenib
2
Radiation Dose Hypofractionation
2
Quality of Life
2
Nivolumab
2
Molecular Diagnostic Techniques
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Synovial
×
Drug Therapy
×
Sarcoma
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled